Craft

Cullinan Oncology

Stock Price

$16.9

2024-10-29

Market Capitalization

$981 M

2024-10-29

Revenue

$18.9 M

FY, 2021

Cullinan Oncology Summary

Company Summary

Overview
Cullinan Oncology is a company that develops cancer treatments and a portfolio of oncology therapeutics. It offers business models for traditional drug development, portfolio management for distributing risk and streamlining the development of drugs. Cullinan Oncology caters to cancer hospitals, biopharmaceutical companies, and drug development organizations.
Type
Public
Status
Active
Founded
2016
HQ
Cambridge, MA, US | view all locations
Website
https://www.cullinanoncology.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Nadim Ahmed

    Nadim Ahmed, President, Chief Executive Officer & Director

  • Patrick Baeuerle

    Patrick Baeuerle, Scientific Advisory Board Member

  • Kevin A. Johnston

    Kevin A. Johnston, Chief Technical Operations Officer

  • Jennifer Michaelson

    Jennifer Michaelson, Chief Scientific Officer

Operating MetricsView all

Discovery Stage Products

4

Q3, 2020

IND-Enabling Stage Products

2

Q3, 2020

Phase I Trials Products

1

Q3, 2020

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    Massachusetts Ave

Cullinan Oncology Financials

Summary Financials

Net income (Q1, 2026)
($49.7M)
Cash (Q1, 2026)
$75.1M
EBIT (Q1, 2026)
($53.7M)
Enterprise value
$908.3M

Footer menu